Title

A narrative review of emergency use authorization versus full fda approval and its effect on covid-19 vaccination hesitancy

Authors

Thoyaja Koritala, Mayo Clinic
Akbar Hussain, Keystone Health
Yelena Pleshkova, UH College of Medicine
Lavanya Dondapati, Baylor St. Luke's Medical Center
Raghavendra Tirupathi, Penn State College of Medicine
Ali A. Rabaan, Johns Hopkins Aramco Healthcare
Abbas Al Mutair, Almoosa Specialist Hospital
Saad Alhumaid, Ministry of Health Saudi Arabia
Jaffar A. Al-Tawfiq, Johns Hopkins Aramco Healthcare
Rahul Kashyap, Mayo Clinic

Publication Name

Infezioni in Medicina

Abstract

COVID-19 pandemic affected the lives of many with its devastating mortality and morbidity. Acquisition of herd immunity is one way to mitigate the spread of infection. Many factors influence the acceptance of vaccination including the regulatory process of the vaccines. This review article will briefly summarize the Emergency Use Authorization, Full FDA Approval process and highlight how the key factors affecting the vaccination hesitancy, are being influenced by the lack of Full FDA Approval.

Open Access Status

This publication may be available as open access

Volume

29

Issue

3

First Page

339

Last Page

344